Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial

Fig. 2

The improvement of metabolic data in two groups of newly diagnosed T2DM patients after treatment. A Weight B Systolic blood pressure (SBP) C Diastolic blood pressure (DBP) D Triglyceride (TG) E Total cholesterol (CHO-L) F Low density lipoprotein (LDL) G uric acid (UA) H. Serum creatinine (Scr) I Fasting blood glucose (FBG) J glycosylated hemoglobin (HbA1c) * P < 0.05,** P < 0.01

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us